Shigehira Saji

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios et al. · The Lancet · 2020 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +16

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Estrogen receptor (ER) β, a modulator of ERα in the uterus

Shigehira Saji, Sirpa Mäkinen, Guojun Cheng et al. · Proceedings of the National Academy of Sciences · 2000 · 508 citations

Life Sciences, Endocrinology, Physiology +17

A role for estrogen receptor β in the regulation of growth of the ventral prostate

Sari Mäkelä, Leif C. Andersson, Saija Salmi et al. · Proceedings of the National Academy of Sciences · 2001 · 439 citations · Full text

Life Sciences, Endocrinology, Urology +16

Estrogen receptors α and β in the rodent mammary gland

Shigehira Saji, Elwood V. Jensen, Stefan Nilsson et al. · Proceedings of the National Academy of Sciences · 2000 · 360 citations

Life Sciences, Cell Biology, Endocrinology +15